N. Doktorova

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis

D. Kudlay, N. Nikolenko, N. Doktorova, 2021, FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology.

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis

D. Kudlay, N. Stavitskaya, N. Doktorova, 2020, Tuberculosis and lung diseases.

Possibilities of the Enzyme-Linked Immunospot Assay (Elispot) method in carrying out anti-tuberculosis measures in patients with HIV infection

D. Kudlay, E. Borodulina, B. Borodulin, 2021, Immunologiya.

Impact of Active Case Finding on Clinical Structure and Severity of Tuberculosis in School-Aged Children (7-15 Years Old)

D. Kudlay, V. Аksenova, S. Sterlikov, 2022, Tuberculosis and lung diseases.

Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance

S. Borisov, N. Doktorova, D. Kudlay, 2023, FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology.

VALIDITY OF A NEGATIVE SKIN TEST RESULT WITH RECOMBINANT TUBERCULOSIS ALLERGEN IN ORDER TO EXCLUDE THE ACTIVE TUBERCULOSIS IN CHILDREN

I. Vasilyeva, V. Aksenova, A. Kazakov, 2022, Pediatria. Journal named after G.N. Speransky.